Treatment with a chimeric CD4 monoclonal antibody is associated with a relative loss of CD4+/CD45RA+ cells in patients with rheumatoid arthritis. (Q52044023)
Jump to navigation
Jump to search
scientific article published in February 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with a chimeric CD4 monoclonal antibody is associated with a relative loss of CD4+/CD45RA+ cells in patients with rheumatoid arthritis. |
scientific article published in February 1997 |
Statements
Treatment with a chimeric CD4 monoclonal antibody is associated with a relative loss of CD4+/CD45RA+ cells in patients with rheumatoid arthritis. (English)
1 reference
van der Lubbe PA
1 reference
Breedveld FC
1 reference
Tak PP
1 reference
Schantz A
1 reference
Woody J
1 reference
Miltenburg AM
1 reference
1 February 1997
1 reference
10
1 reference
1
1 reference
87-97
1 reference